4//SEC Filing
WENTWORTH KORY JAMES 4
Accession 0001725663-25-000004
CIK 0001689375other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:30 PM ET
Size
5.4 KB
Accession
0001725663-25-000004
Insider Transaction Report
Form 4
WENTWORTH KORY JAMES
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-21$9.98/sh−8,910$88,932→ 110,026 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $10.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001725663
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:30 PM ET
- Size
- 5.4 KB